Articoli con mandati relativi all'accesso pubblico - James W F CattoUlteriori informazioni
Non disponibili pubblicamente: 15
Controlla
Repeat transurethral resection in non–muscle-invasive bladder cancer: a systematic review
MGK Cumberbatch, B Foerster, JWF Catto, AM Kamat, W Kassouf, ...
European urology 73 (6), 925-933, 2018
Mandati: National Institute for Health Research, UK
Controlla
Molecular characterization of upper tract urothelial carcinoma in the era of next-generation sequencing: a systematic review of the current literature
MR Hassler, F Bray, JWF Catto, AP Grollman, A Hartmann, V Margulis, ...
European urology 78 (2), 209-220, 2020
Mandati: US Department of Defense
Controlla
Prehabilitation exercise before urologic cancer surgery: a systematic and interdisciplinary review
LG Briggs, C Reitblat, PA Bain, S Parke, NY Lam, J Wright, JWF Catto, ...
European Urology 81 (2), 157-167, 2022
Mandati: National Institute for Health Research, UK
Controlla
Comparing an imaging-guided pathway with the standard pathway for staging muscle-invasive bladder cancer: preliminary data from the BladderPath study
RT Bryan, W Liu, SJ Pirrie, R Amir, J Gallagher, AI Hughes, KP Jefferson, ...
European urology 80 (1), 12-15, 2021
Mandati: Cancer Research UK, National Institute for Health Research, UK
Controlla
Non-visible haematuria for the detection of bladder, upper tract, and kidney cancer: an updated systematic review and meta-analysis
I Jubber, SF Shariat, S Conroy, WS Tan, PC Gordon, Y Lotan, ...
European urology 77 (5), 583-598, 2020
Mandati: National Institute for Health Research, UK
Controlla
Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit
A Vickers, F O’Brien, F Montorsi, D Galvin, O Bratt, S Carlsson, JWF Catto, ...
bmj 381, 2023
Mandati: US National Institutes of Health, National Institute for Health Research, UK
Controlla
Next-generation RNA sequencing of archival formalin-fixed paraffin-embedded urothelial bladder cancer
YU Liu, AP Noon, EA Cabeza, J Shen, C Kuk, C Ilczynski, R Ni, B Sukhu, ...
European urology 66 (6), 982-986, 2014
Mandati: Canadian Cancer Society, European Commission
Controlla
Optimal dissemination of scientific manuscripts via social media: A prospective trial comparing visual abstracts versus key figures in consecutive original manuscripts …
Z Klaassen, E Vertosick, AJ Vickers, MJ Assel, G Novara, C Pierce, ...
European urology 82 (6), 633-636, 2022
Mandati: US National Institutes of Health
Controlla
Occupation and bladder cancer phenotype: identification of workplace patterns that increase the risk of advanced disease beyond overall incidence
AP Noon, JI Martinsen, JWF Catto, E Pukkala
European urology focus 4 (5), 725-730, 2018
Mandati: Yorkshire Cancer Research, UK
Controlla
Comparing open-radical cystectomy and robot-assisted radical cystectomy: current status and analysis of the evidence
P Khetrapal, S Conroy, JD Kelly, JWF Catto
Current Opinion in Urology 30 (3), 400-406, 2020
Mandati: National Institute for Health Research, UK
Controlla
Race reporting and disparities regarding clinical trials in bladder cancer: a systematic review
E Freudenburg, I Bagheri, S Srinivas, A Martinez, N Putluri, Z Klaassen, ...
Cancer Causes & Control 33 (8), 1071-1081, 2022
Mandati: US Department of Defense, US National Institutes of Health, Cancer Research …
Controlla
Impact of anaesthetist volume on radical cystectomy outcomes
I Jubber, KH Pang, R Groves, O Reed, AP Noon, JWF Catto, ...
European Urology Focus 7 (1), 117-123, 2021
Mandati: National Institute for Health Research, UK
Controlla
The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients: a systematic review
E Rammant, L Fox, K Beyer, NK Aaronson, R Chaloner, S De Padova, ...
Quality of life research 32 (8), 2127-2135, 2023
Mandati: National Institute for Health Research, UK
Controlla
The development of the cystectomy‐pathway assessment tool (C‐PAT): a concise tool to assess the quality of care in the cystectomy pathway
AD Uren, N Cotterill, P Abrams, JWF Catto, B Patel, J McGrath, I Ahmed, ...
BJU international 129 (6), 708-717, 2022
Mandati: Cancer Research UK
Controlla
Digital tracking of patients undergoing radical cystectomy for bladder cancer: daily step counts before and after surgery within the iROC randomised controlled trial
P Khetrapal, PS Bains, I Jubber, G Ambler, NR Williams, C Brew-Graves, ...
European Urology Oncology 7 (3), 485-493, 2024
Mandati: National Institute for Health Research, UK
Disponibili pubblicamente: 168
Controlla
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
Mandati: US Department of Defense, US National Institutes of Health
Controlla
10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer
FC Hamdy, JL Donovan, JA Lane, M Mason, C Metcalfe, P Holding, ...
New England Journal of Medicine 375 (15), 1415-1424, 2016
Mandati: Cancer Research UK, National Institute for Health Research, UK, UK Research …
Controlla
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
Mandati: US Department of Defense, US National Institutes of Health
Controlla
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
Mandati: US National Institutes of Health
Controlla
Comprehensive molecular characterization of muscle-invasive bladder cancer
AG Robertson, J Kim, H Al-Ahmadie, J Bellmunt, G Guo, AD Cherniack, ...
Cell 171 (3), 540-556. e25, 2017
Mandati: US Department of Defense, US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software